Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

October 2020 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In October 2020, FDA received 116,289 drug adverse event reports. In October 2019, FDA received 108,803.

In October 2020, FDA received 156,471 medical device reports. In October 2019, FDA received 126,821.

By drug reports received, October 2020 was number 8 of the 12 months of 2020. FDA received 120,084 drug reports a month on average in the 12 months before October 2020.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to October 2020
0100,000200,000201820192020

Drugs in the reports

The table has the 141 drug pages with 250 or more reports in October 2020. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of October 2020 name as a suspect product, in order of name
DrugReports in the month
Abatacept290
Acetaminophen253
Actemra888
Aimovig616
Albuterol sulfate478
Alprazolam292
Amlodipine281
Apixaban1,095
Arava352
Atripla711
Azathioprine325
Azithromycin Anhydrous384
Bevacizumab269
Breo Ellipta261
Buprenorphine Transdermal Patch281
Capecitabine388
Carboplatin512
Ceftriaxone291
Cimzia408
Cisplatin318
Clozapine272
Clozaril255
Complera477
Cosentyx1,453
Cyclophosphamide691
Cytarabine299
Dexamethasone873
Diazepam256
Diclofenac sodium794
Dilaudid822
Duodopa300
Dupixent1,742
Eligard327
Eliquis803
Emgality978
Enbrel1,406
Entresto1,134
Epidiolex266
Etoposide398
Fentanyl408
Fluorouracil250
Furosemide332
Gabapentin319
Gilenya402
Heroin273
Humalog367
Humira2,876
Hydrocodone bitartrate and acetaminophen1,294
Hydromorphone Tablets438
Hydroxychloroquine855
Hydroxychloroquine sulfate386
Ibrance994
Ibuprofen394
Imbruvica735
Inflectra307
Infliximab519
Infliximab Recombinant468
Ingrezza394
Insulin glargine256
Jakafi427
Jardiance277
Keytruda353
Lamotrigine289
Leflunomide378
Levetiracetam361
Linzess931
Lyrica526
Mepolizumab273
Metformin481
Methadone315
Methotrexate1,649
Methotrexate sodium416
Methylprednisolone430
Mirena517
Morphine sulfate909
MS Contin579
Mycophenolate mofetil511
Neulasta810
Nexplanon293
Nivolumab461
Nucala349
Nuplazid336
Ocrevus326
Olanzapine301
Omeprazole381
Opdivo334
Opsumit274
Orencia1,107
Otezla1,163
Oxaliplatin364
Oxycodone297
Oxycodone and acetaminophen1,203
Oxycodone hydrochloride2,663
OxyContin2,595
Oxyir266
Paclitaxel334
Pantoprazole297
Paracetamol365
Percocet432
Pomalyst717
Prednisolone615
Prednisone1,330
Pregabalin251
Prolia480
Quetiapine305
Remdesivir517
Remicade946
Remodulin258
Repatha643
Revlimid2,626
Rinvoq279
Rituximab1,775
Simponi524
Skyrizi321
Stelara874
Stribild507
Suboxone357
Sulfasalazine426
Symbicort563
Tacrolimus618
Taltz263
Tecfidera736
Tiotropium bromide358
Tramadol954
Tresiba422
Trulicity1,639
Truvada967
Tukysa351
Tysabri402
Vedolizumab466
Venclexta301
Vicodin279
Viread739
Voltaren Arthritis Pain451
Vraylar656
Xarelto555
Xeljanz1,707
Xyrem366
Zantac8,177
Zejula251
Zytiga364

Reaction terms in the reports

The table has the 150 reaction terms with 500 or more reports in October 2020. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of October 2020 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort1,121
Abdominal distensiona bloated abdomen567
Abdominal painstomach or belly pain1,233
Abdominal pain upperupper stomach pain1,130
Accidental exposure to product609
Acneacne572
Acute kidney injurysudden loss of kidney function1,270
Alopeciahair loss1,079
Anaemialow red blood cells911
Anhedonia922
Anxietyanxiety2,476
Arthralgiajoint pain2,414
Arthritis502
Astheniaweakness or lack of energy2,016
Asthmaasthma1,082
Atrial fibrillationan irregular heart rhythm658
Back painback pain1,225
Balance disorderproblems with balance508
Bladder cancer1,013
Blood glucose increasedraised blood sugar reading992
Blood pressure increaseda raised blood pressure reading978
Bone density decreased819
Cardiac disorder653
Cerebrovascular accidentstroke875
Chest discomfortchest discomfort597
Chest painchest pain876
Chillschills or shivering591
Chronic kidney diseaselong-term kidney disease689
Colorectal cancer1,567
Condition aggravatedthe condition being treated got worse2,169
Confusional stateconfusion776
Constipationconstipation1,334
Coughcough1,558
Covid-19COVID-19 infection1,699
Deaththe patient died; cause not stated by this term5,581
Decreased appetitereduced appetite1,401
Dehydrationdehydration698
Depressionlow mood1,366
Device issuea problem with the device525
Device malfunctionthe device did not work properly503
Diarrhoealoose or frequent stools4,096
Disease progressionthe disease advanced594
Dizzinesslight-headedness or unsteadiness2,383
Drug abusemisuse of a medicine770
Drug dependencedependence on a medicine3,012
Drug hypersensitivityan allergic-type reaction (the term names a medicine)1,120
Drug ineffectivethe medicine did not work as expected8,468
Drug interactionan interaction between medicines896
Drug intolerancethe medicine was not tolerated768
Dry skindry skin863
Dyspepsiaindigestion534
Dyspnoeashortness of breath3,369
Emotional distressemotional distress1,414
Erythemaskin redness1,225
Falla fall1,752
Fatiguetiredness4,322
Feeling abnormalfeeling odd or not right1,337
Gait disturbancedifficulty walking982
Gastrointestinal disorder575
General physical health deteriorationgeneral decline in health747
Haemoglobin decreasedlow haemoglobin525
Haemorrhagebleeding506
Headachehead pain3,411
Heart rate increaseda fast heart rate reading633
Hospitalisationadmission to hospital1,241
Hyperhidrosisexcessive sweating641
Hypersensitivityan allergic-type reaction977
Hypertensionhigh blood pressure1,200
Hypoaesthesianumbness711
Hypotensionlow blood pressure1,089
Illness1,264
Inappropriate schedule of product administrationthe product was taken at the wrong times2,056
Incorrect dose administeredthe wrong dose was given986
Infectionan infection, type not specified874
Infusion related reactiona reaction during or soon after an infusion518
Injection site painpain where the injection was given1,159
Injurya physical injury950
Insomniadifficulty sleeping1,323
Intentional product use issuedeliberate use not as intended1,221
Joint swellinga swollen joint772
Loss of consciousnesspassing out698
Loss of personal independence in daily activities622
Malaisegeneral feeling of being unwell2,095
Malignant neoplasm progression600
Memory impairmentmemory problems840
Migrainemigraine675
Muscle spasmsmuscle cramps823
Muscular weaknessmuscle weakness533
Musculoskeletal stiffnessstiffness in muscles or joints504
Myalgiamuscle pain736
Myocardial infarctionheart attack628
Nasopharyngitisa cold814
Nauseafeeling sick4,209
Neoplasm malignanta cancer, type not specified1,126
Neuropathy peripheralnerve damage in hands or feet689
Neutropenialow neutrophils, a type of white blood cell716
No adverse eventno adverse event was reported637
Oesophageal carcinoma645
Off label useused for a purpose or in a way not on the label6,525
Oropharyngeal painsore throat519
Overdosea dose above the recommended amount2,142
Painpain, site not specified4,337
Pain in extremitypain in an arm or leg1,561
Palpitationsawareness of the heartbeat530
Paraesthesiatingling or pins and needles686
Peripheral swellingswelling of the arms or legs1,113
Platelet count decreasedlow platelet count642
Pneumonialung infection1,749
Product dose omission issuea dose was missed3,519
Product quality issuea problem with the product itself545
Product storage errorthe product was stored wrongly510
Product use in unapproved indicationused for a purpose not on the label2,233
Product use issuea problem in how the product was used1,194
Prostate cancer693
Pruritusitching1,907
Psoriasispsoriasis, a skin condition831
Pyrexiafever1,881
Rashskin rash2,378
Renal cancer1,014
Renal failurekidney failure782
Renal impairmentreduced kidney function535
Renal injury688
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease824
Seizurea fit or convulsion1,008
Sepsisa severe body-wide response to infection646
Sinusitissinus infection566
Skeletal injury628
Skin exfoliationpeeling skin512
Somnolencedrowsiness1,195
Swellingswelling507
Therapeutic product effect incomplete1,205
Therapy interrupted738
Thrombocytopenialow platelets627
Thrombosis576
Tooth loss581
Toxicity to various agentspoisoning or toxic effect of one or more substances1,270
Treatment failurethe treatment did not work611
Tremorshaking834
Unevaluable eventthe event could not be assessed603
Urinary tract infectionbladder or urinary infection974
Urticariahives799
Vision blurredblurred vision562
Visual impairmentreduced vision770
Vomitingbeing sick2,467
Weight decreasedweight loss1,851
Weight increasedweight gain1,387
Wheezingwheezing512
White blood cell count decreasedlow white cell count659
Wrong technique in device usage process552
Wrong technique in product usage processthe product was used in the wrong way1,311

Devices in the reports

The table has the 57 device pages with 250 or more reports in October 2020. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of October 2020 name, in order of name
Brand nameReports in the month
630G Insulin PUMP MMT-1715K 630G BLACK MG1,293
630G Insulin PUMP MMT-1715KL 630G395
640G Insulin Pump MMT-1711K1,138
640G Insulin Pump MMT-1712K2,010
670G Insulin Pump MMT-1780KL1,117
8015 Alaris System Pc Unit1,381
8100 Alaris Pump Module3,260
8110 Alaris Syringe Pump1,013
8120 Alaris Pca259
Alaris Pc Unit602
Alaris Pca648
Alaris Pump Module3,101
Alaris Syringe Pump485
Alaris System Pc Unit2,308
Bd Rapid Detection Of Sars-Cov-2 Veritor Assay342
Biohorizons Dental Implant482
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim382
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP298
Cadd317
CapSureFix Novus Lead MRI SureScan970
Dexcom G5 Mobile Continuous Glucose Monitoring System483
Dexcom G6 Continuous Glucose Monitoring System21,468
Emblem Mri S-Icd346
Emblem S-Icd302
Essure827
HeartWare Ventricular Assist System - Pump825
Ingevity Mri425
Inspira Smooth Silicone Gel Filled Breast Implant299
Inspira Textured Silicone Gel Filled Breast Implant341
Intellis328
Libre 2 Sensor FreeStyle329
Libre Sensor Freestyle1,097
LifeVest WCD 4000 System1,176
MENTOR MemoryGel Breast Implant663
NobelActive Internal RP 4.3x10mm461
NobelActive Internal RP 4.3x11.5mm372
NobelActive Internal RP 4.3x13mm292
NobelParallel CC RP 4.3x10mm362
NobelParallel CC RP 4.3x11.5mm263
Octrode Lead Kit, 60cm Length492
Omnipod DASH Insulin Management System379
Omnipod Insulin Management System927
Perclose Proglide 6f Suture Mediated Closure Smc System329
Proclaim 5 Elite Implantable Pulse Generator250
Pump MMT-1780KPK 670G Pathway Black MG4,249
Pump Mmt-1782k 670g V4 11 Mm450
Spectrum Infusion Pump365
Sprint Quattro Secure S MRI SureScan330
Style 68 Saline Filled Breast Implant357
T Slim G5 System466
t:slim X2 Insulin Pump438
t:slim X2 Insulin Pump with Basal-IQ Technology2,323
t:slim X2 Insulin Pump with Control-IQ Technology3,503
t:slim X2 Insulin Pump with Interoperable Technology464
Tendril Sts426
Unknown Implant659
V60 Ventilator432

Cite this page

Reported Reactions. October 2020: adverse event reports received by FDA. https://reportedreactions.com/month/2020-10/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for October 2020 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 116,289 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.